BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36773118)

  • 21. Imaging of pancreatic cystic lesions with confocal laser endomicroscopy: an ex vivo pilot study.
    Kadayifci A; Atar M; Yang M; Fernandez-Del Castillo C; Mino-Kenudson M; Brugge WR
    Surg Endosc; 2017 Dec; 31(12):5119-5126. PubMed ID: 28444494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Invasive Intraductal Papillary Mucinous Neoplasms: CT Features of Colloid Carcinoma Versus Tubular Adenocarcinoma of the Pancreas.
    Fouladi DF; Raman SP; Hruban RH; Fishman EK; Kawamoto S
    AJR Am J Roentgenol; 2020 May; 214(5):1092-1100. PubMed ID: 32130045
    [No Abstract]   [Full Text] [Related]  

  • 23. Etiologic Distribution of Pancreatic Cystic Lesions Identified on Computed Tomography/Magnetic Resonance Imaging.
    Munigala S; Javia SB; Agarwal B
    Pancreas; 2019 Sep; 48(8):1092-1097. PubMed ID: 31404022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphoepithelial cysts of the pancreas: an EUS case series.
    Nasr J; Sanders M; Fasanella K; Khalid A; McGrath K
    Gastrointest Endosc; 2008 Jul; 68(1):170-3. PubMed ID: 18513719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cystic neoplasia of the pancreas: pathology and biology.
    Adsay NV
    J Gastrointest Surg; 2008 Mar; 12(3):401-4. PubMed ID: 17957438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Branch-duct intraductal papillary mucinous neoplasm (IPMN): Are cyst volumetry and other novel imaging features able to improve malignancy prediction compared to well-established resection criteria?
    Pozzi Mucelli RM; Moro CF; Del Chiaro M; Valente R; Blomqvist L; Papanikolaou N; Löhr JM; Kartalis N
    Eur Radiol; 2022 Aug; 32(8):5144-5155. PubMed ID: 35275259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancreatic cystic neoplasms and post-inflammatory cysts: interobserver agreement and diagnostic performance of MRI with MRCP.
    Tirkes T; Patel AA; Tahir B; Kim RC; Schmidt CM; Akisik FM
    Abdom Radiol (NY); 2021 Sep; 46(9):4245-4253. PubMed ID: 34014363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
    Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
    Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Size of mural nodule as an indicator of surgery for branch duct intraductal papillary mucinous neoplasm of the pancreas during follow-up.
    Uehara H; Ishikawa O; Katayama K; Kawada N; Ikezawa K; Fukutake N; Takakura R; Takano Y; Tanaka S; Takenaka A
    J Gastroenterol; 2011 May; 46(5):657-63. PubMed ID: 21085997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-Term Surveillance and Timeline of Progression of Presumed Low-Risk Intraductal Papillary Mucinous Neoplasms.
    Kayal M; Luk L; Hecht EM; Do C; Schrope BA; Chabot JA; Gonda TA
    AJR Am J Roentgenol; 2017 Aug; 209(2):320-326. PubMed ID: 28590817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical treatment for pancreatic cystic lesions-implications from the multi-center and prospective German StuDoQ|Pancreas registry.
    Henn J; Wyzlic PK; Esposito I; Semaan A; Branchi V; Klinger C; Buhr HJ; Wellner UF; Keck T; Lingohr P; Glowka TR; Manekeller S; Kalff JC; Matthaei H;
    Langenbecks Arch Surg; 2023 Jan; 408(1):28. PubMed ID: 36640188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synchronous pancreatic solid pseudopapillary neoplasm and intraductal papillary mucinous neoplasm.
    Hirabayashi K; Zamboni G; Ito H; Ogawa M; Kawaguchi Y; Yamashita T; Nakagohri T; Nakamura N
    World J Gastroenterol; 2013 Jun; 19(21):3358-63. PubMed ID: 23745041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nature and management of pancreatic mucinous cystic neoplasm (MCN): A systematic review of the literature.
    Nilsson LN; Keane MG; Shamali A; Millastre Bocos J; Marijinissen van Zanten M; Antila A; Verdejo Gil C; Del Chiaro M; Laukkarinen J
    Pancreatology; 2016; 16(6):1028-1036. PubMed ID: 27681503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cystic pancreatic tumors: diagnostics and new biomarkers].
    Berger AW; Seufferlein T; Kleger A
    Chirurg; 2017 Nov; 88(11):905-912. PubMed ID: 28831506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Not all mixed-type intraductal papillary mucinous neoplasms behave like main-duct lesions: implications of minimal involvement of the main pancreatic duct.
    Sahora K; Fernández-del Castillo C; Dong F; Marchegiani G; Thayer SP; Ferrone CR; Sahani DV; Brugge WR; Warshaw AL; Lillemoe KD; Mino-Kenudson M
    Surgery; 2014 Sep; 156(3):611-21. PubMed ID: 25081232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fukuoka criteria accurately predict risk for adverse outcomes during follow-up of pancreatic cysts presumed to be intraductal papillary mucinous neoplasms.
    Mukewar S; de Pretis N; Aryal-Khanal A; Ahmed N; Sah R; Enders F; Larson JJ; Levy MJ; Takahashi N; Topazian M; Pearson R; Vege SS; Chari ST
    Gut; 2017 Oct; 66(10):1811-1817. PubMed ID: 27390303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraductal papillary-mucinous neoplasms and mucinous cystic neoplasms of the pancreas differentiated by ovarian-type stroma.
    Murakami Y; Uemura K; Ohge H; Hayashidani Y; Sudo T; Sueda T
    Surgery; 2006 Sep; 140(3):448-53. PubMed ID: 16934608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of malignancy in resected cystic tumors of the pancreas < or =3 cm in size: is it safe to observe asymptomatic patients? A multi-institutional report.
    Lee CJ; Scheiman J; Anderson MA; Hines OJ; Reber HA; Farrell J; Kochman ML; Foley PJ; Drebin J; Oh YS; Ginsberg G; Ahmad N; Merchant NB; Isbell J; Parikh AA; Stokes JB; Bauer T; Adams RB; Simeone DM
    J Gastrointest Surg; 2008 Feb; 12(2):234-42. PubMed ID: 18040749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "Trivial" Cysts Redefine the Risk of Cancer in Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Potential Target for Follow-Up Discontinuation?
    Marchegiani G; Andrianello S; Pollini T; Caravati A; Biancotto M; Secchettin E; Bonamini D; Malleo G; Bassi C; Salvia R
    Am J Gastroenterol; 2019 Oct; 114(10):1678-1684. PubMed ID: 31449158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of a Revised Management Strategy for Patients With Intraductal Papillary Mucinous Neoplasms Involving the Main Pancreatic Duct.
    Sugimoto M; Elliott IA; Nguyen AH; Kim S; Muthusamy VR; Watson R; Hines OJ; Dawson DW; Reber HA; Donahue TR
    JAMA Surg; 2017 Jan; 152(1):e163349. PubMed ID: 27829085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.